You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創醫療(00853.HK)正考慮一項策略重組集團CRM業務的建議

格隆匯7月16日丨微創醫療(00853.HK)公告,爲推動內部資源的深度整合及高效協作、提升企業競爭力、整合不同業務板塊及產品組合及爲集團及其相關持份者創造長遠價值,公司董事會正考慮一項有關建議策略重組集團CRM業務的不具約束力建議,據此,待與有興趣人士進一步磋商,CRM業務將與微創心通醫療科技有限公司("微創心通",一間於開曼羣島註冊成立的公司,其股份於香港聯合交易所有限公司主板上市(股份代號:2160),於本公告日期爲公司的非全資附屬公司)的業務合併。

公司於開曼羣島註冊成立,其股份於香港聯合交易所有限公司主板上市。公司連同其附屬公司是一間領先的醫療器械集團,專注於在全球範圍內創新、製造及銷售高端醫療器械,業務範疇廣泛。於本公告日期,該等業務分部包括心血管介入、骨科醫療器械、CRM、大動脈及外周血管介入、神經介入、結構性心臟病業務、手術機器人及其他業務。

集團CRM業務致力於打造全球領先的CRM解決方案,主要從事研發、製造及銷售用於診斷、治療及管理心律失常及心力衰竭的產品,主要包括起搏器、除顫器、心臟再同步治療裝置及配套導線產品,以及搭配使用的監測產品組合。

另一方面,集團透過微創心通進行的結構性心臟病業務則專注於結構性心臟病領域創新的經導管解決方案的研發及商業化,並致力於爲醫生及患者普及最先進的整體解決方案,以治療結構性心臟病。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account